Brexit will mean that the European Medicines Agency (EMA) will have to leave London for a city belonging to the European Union. Toulouse, which is a very active city in the areas of science and medicine - oncology in particular - has applied to accommodate this institution, which employs 890 people. Toulouse is also highlighting its commitments in the development of molecular genetics, the future of customised medicine, which the requires high-performance digital research and observation resources in its various laboratories. Lastly, the city has a property offering with dozens of hectares currently to be developed in the metropolitan area, in the Langlade sector, south of Toulouse. In the rest of Europe, Copenhagen, Stockholm, Barcelona and Milan have also applied to accommodate the European Medicines Agency.
Toulouse in the running to accommodate the European Medicines Agency
Thursday, 13 October, 2016